Journal List > Infect Chemother > v.49(1) > 1035468

Kim, Seo, Kim, Kim, Wie, Cho, Lim, Lee, Kwon, Lee, Cheong, Park, Ryu, Chung, and Pai: Usefulness of Blood Cultures and Radiologic Imaging Studies in the Management of Patients with Community-Acquired Acute Pyelonephritis

Abstract

Background

The objective of this study was to examine the usefulness of blood cultures and radiologic imaging studies for developing therapeutic strategies in community-acquired acute pyelonephritis (CA-APN) patients.

Materials and Methods

We prospectively collected the clinical data of CA-APN patients who visited 11 hospitals from March 2010 to February 2011.

Results

Positive urine and blood cultures were obtained in 69.3% (568/820) and 42.7% (277/648), respectively, of a total of 827 CA-APN patients. Blood culture identified the urinary pathogen in 60 of 645 (9.3%) patients for whom both urine and blood cultures were performed; the organisms isolated from urine were inconsistent with those from blood in 11 and only blood cultures were positive in 49 patients. Final clinical failure was more common in the bacteremic patients than the non-bacteremic ones (8.0% vs. 2.7%, P = 0.003), as was hospital mortality (3.6% vs. 0.3%, P = 0.003). Likewise, durations of hospitalization and fever were significantly longer. Bacteremia was independent risk factor for mortality (OR 9.290, 1.145-75.392, P = 0.037). With regard to radiologic studies, the detection rate of APN was 84.4% (445/527) by abdominal computed tomography and 40% (72/180) by abdominal ultrasonography. Eighty-one of 683 patients (11.9%) were found to have renal abscess, perinephric abscess, urolithiasis, hydronephorosis/hydroureter or emphysematous cystitis, which could potentially impact on clinical management. Patients with Pitt score ≥ 1, flank pain or azotemia were significantly more likely to have such structural abnormalities.

Conclusion

Blood cultures are clinically useful for diagnosis of CA-APN, and bacteremia is predictive factor for hospital mortality. Early radiologic imaging studies should be considered for CA-APN patients with Pitt scores ≥1, flank pain or azotemia.

Introduction

Acute pyelonephritis (APN) refers to infection of the renal pelvis and the parenchyma. It generally occurs due to ascending infection via the bladder [12]. The annual prevalence of acute pyelonephritis in Korea is 35.7/10,000 people, and is higher in women than in men (59/10,000 vs. 12.6/10,000) [3]. The disease is diagnosed by identifying the pathogen in urine cultures, as well as by the clinical symptoms of fever, flank pain, costovertebral angle (CVA) tenderness and urinary symptoms such as frequency of urination, urgency, and dysuria [4]. In addition, blood cultures are commonly conducted in patients with APN, but the usefulness of these has not been supported in several reports [2567]. However, the utility of the test may differ according to the host, antibiotic exposure before hospital visit and rate of positive culture.
Radiologic imaging studies such as computed tomography (CT) and renal ultrasonography (US) are conducted to diagnose structural problems such as ureteral obstruction or renal abscess in some patients with unsatisfactory clinical response to antibiotic treatment [2].
The aforementioned diagnostic tools have been widely used in clinical practice, but little is known about how frequently they are used and whether they influence the management of APN patients. Accordingly, this prospective study was conducted in a cohort of community-acquired APN (CA-APN) patients to examine the usefulness of blood cultures and radiologic imaging studies for making therapeutic decisions.

Materials and Methods

Clinical data on CA-APN patients were collected from 11 general hospitals with 500-1,250 beds from March 2010 to February 2011. Ten of the 11 hospitals were university hospitals. The study protocol was reviewed and approved by the Institutional Review Boards (IRBs) of the participating hospitals. Personal information was encrypted, and informed consent was waived by the IRBs.
Patients with fever ≥37.8˚C who satisfied at least 3 of the following 5 conditions were included in this study: (1) frequency of urination, dysuria, or suprapubic tenderness as symptoms of lower urinary tract infection; (2) flank pain; (3) CVA tenderness; (4) pyuria defined as white blood cell (WBC) count ≥10 in a high power field in urinalysis; and (5) leukocytosis defined as WBC count ≥20,000/mm3 or polymorphonuclear cell count ≥ 65% in peripheral blood tests [89]. Patients under 15 years old, those with other reasons for pyuria and fever, and those with insufficient data were excluded. The study subjects were clinically diagnosed by infectious disease experts in the participating hospitals.
Urine and blood cultures were processed at the time of admission. Etiologic agents were determined when organisms at ≥105 colony forming unit (CFU)/mL were identified in urine cultures and/or urinary pathogens were isolated from blood cultures. Species identification and susceptibilities to antimicrobial agents were determined by means of a semiautomated system (VITEK, bioMerieux, Hazelwood, MO, USA; or Microscan, DADE Behring, West Sacramento, CA, USA) [10]. CT was considered diagnostic for APN if single or multiple hypodense parenchymal areas were seen after infusion of contrast medium , and local low-echo contrast with an unclear boundary caused by renal interstitial edema was diagnostic in abdominal US [11] performed by radiologists in each hospital.
The patients' demographics, disease history, clinical symptoms and signs, and treatment outcomes were prospectively collected via a web-based medical records system. Disease history included antibiotic use, history of urinary treat infection (UTI), and history of admission in the past year. The clinical symptoms and signs included flank pain, signs of lower urinary tract infection, CVA tenderness, and nausea/vomiting. Pitt score was made up of: (1) oral temperature (2 points for ≤35°C or ≥40°C, 1 point for 35.1-36.0°C or 39.0-39.9°C, and 0 point for 36.1-38.9°C); (2) acute hypotension (2 points for an systemic blood pressure decrease >30 mmHg and a diastolic blood pressure decrease >20 mmHg; (3) ventilator use (2 points); (4) heart failure (4 points); and (5) consciousness (0 point for alertness, 1 point for disorientation, 2 points for stupor, and 4 points for coma) [12]. Azotemia was defined as serum blood urea nitrogen (BUN) ≥20 mg/dL and/or serum creatinine ≥2.0 mg/dL. Discordant therapy was defined as cases whose empirical antimicrobial therapy regimen was changed due to the drug resistance. Variables reflecting clinical outcome included final clinical failure, hospital mortality, hospitalization days, and time to fever clearance. Final clinical failure was defined as recurrence of symptoms of UTIs within 7-14 days of follow-up, or death.
In terms of evaluation of the diagnostic tests, positive rates and agreement between urine and blood culture were investigated, and positive rates of abdominal US and CT were examined. In addition, we assessed whether the above diagnostic tests affected therapeutic decisions such as interventional treatment or treatment duration. In connection with the radiologic findings, structural abnormalities were defined as lesions which could potentially impact treatment duration or modalities such as urolithiasis, hydronephrosis/hydroureter, renal abscess, perinephric abscess and emphysematous nephritis or cystitis.
Statistical methods: Categorical variables were compared with the Chi-square test or Fisher's exact test, and continuous variables with the Mann-Whitney tests. Univariate and multivariate logistic regression analysis was performed using backward method. A P-value of <0.05 was considered statistically significant. Statistical analyses were conducted using SPSS version 18.0 for Windows (SPSS Inc., Chicago, IL, USA).

Results

A total of 827 patients with CA-APN were enrolled. Their demographic characteristics, underlying diseases and past histories are summarized in Table 1.
Table 1

Demographics and underlying diseases of the study subjects

ic-49-22-i001
Characteristics No. (%), total = 827
Age (years, mean ± SD) 55.4 ± 19.0
Sex
 Male 54 (6.5)
 Female 773 (93.5)
Co-morbidity
 Cerebrovascular disorder 77 (9.3)
 Congestive heart failure 41 (5.7)
 Connective tissue disease 13 (1.6)
 Malignancy 30 (3.6)
 Chronic pulmonary disease 21 (2.5)
 Liver disease 27 (3.3)
 Pregnancy 8 (1.0)
 Diabetes mellitus
 Chronic renal disease 50 (6.0)
Underlying urinary tract abnormality
 Hyperplasia of prostate 11 (1.3)
 Neurogenic bladder 7 (0.8)
 Urolithiasis 14 (1.7)
 Vesicoureteral reflux 3 (0.4)
 Intermittent catheterization 6 (0.7)
 Polycystic kidney disease 7 (0.8)
Past history
 History of admission within 1 year 192 (23.2)
 History of antibiotics use within 1 year 232 (28.1)
 History of urinary tract infection within 1 year 99 (12.0)

1. Performance and positive rates of urine and blood cultures

Urine and blood cultures were carried out in 820 (99.2%) and 648 (78.4%) of the 827 patients, respectively, and the positive rates were 69.3% (568/820) and 42.7% (277/648), respectively (Table 2). Escherichia coli was the most commonly isolated pathogen in both urine and blood cultures: 90.1% (512/568) in urine and 82.7% (229/277) in blood. Among 225 patients with positive urine and blood cultures, the organisms isolated from urine were consistent with those isolated from blood in 214 patients (95.1%), but inconsistent in 11 patients (4.9%). Of the 645 patients who underwent both of urine and blood cultures, 49 (7.6%) were diagnosed via their blood cultures because their urine cultures were negative. The initial antibiotic regimen was modified in 179 patients (21.7%), 95 of whom changed regimen because of the results of antimicrobial susceptibility tests: 15 patients (15.8%) after blood culture results and 80 (84.2%) after urine culture results.
Table 2

Positivity of cultures of blood and urine

ic-49-22-i002
Total = 827
N (%)
Obtained cultures
 Urine 820/827 (99.2%)
 Blood 648/827 (78.4%)
 Both 645/827 (78.0%)
Positive isolates in urine culture only 343/820 (41.8%)
Positive isolates in blood culture onlya 52/648 (8.0%)
Positive isolates in blood and urine culture 225/645 (34.9%)
 Identical pathogens 214/225 (95.1%)
 Different pathogens 11/225 (4.9%)
No growth in urine and blood cultures 144/645 (23.3%)
aThree of the 52 patients with only positive blood cultures did not undergo urine culture

2. Clinical influence of positive blood cultures on the patients with CA-APN

We investigated the effect of bacteremia on disease course among the 648 patients from whom blood cultures were obtained, by dividing them into those with bacteremia and those without bacteremia according to the culture results. Clinical characteristics and treatment outcomes of the two groups were compared (Table 3). The numbers of elderly patients ≥ 70 years and those with a Charlson comorbidity index ≥1 were higher in the bacteremia group than the non-bacteremia group, and clinical illness was more severe in the former: there were more patients with Pitt score ≥1, WBC count ≥20,000/mm3 and C-reactive protein (CRP) ≥20 mg/dL in the bacteremia group. Accordingly, final clinical failure was more common in the bacteremia group (8.0% vs. 2.7%, P = 0.003) and deaths were also more frequent: 3.6% (9/251) vs 0.3% (1/338). Likewise, durations of hospitalization and fever were also longer in the former group. For evaluation of clinical effect of bacteremia on clinical outcomes including hospital mortality and final clinical failure, univariate and multivariate logistic regression test was performed (Table 4). Input variables was included as follows: age ≥70 years, Chalson comorbidity index ≥1, diabetes mellitus, chronic renal disease, WBC ≥20,000/mm3, CRP ≥20 mg/dL, positive blood culture and discordant therapy. Among above variables, positive blood culture was significant predictor for hospital mortality (OR 9.290, 95% CI 1.145-75.392, P = 0.037), although not for final clinical failure.
Table 3

Comparison of the clinical features of the CA-APN patients with positive and negative blood cultures

ic-49-22-i003
Clinical characteristics Positive
Blood culture (N = 277)
n (%)
Negative
Blood culture (N = 371)
n (%)
P-value
Age≥70 years 111 (40.1) 80 (21.6) <0.001
Past history
 History of urinary tract infection within 1 years 64/231(27.7) 100/341(29.3) 0.674
 History of admission within 1 year 81/256 (31.6) 72/345 (20.9) 0.003
 History of antibiotics use within 1 year 69/217 (31.8) 117/323 (36.2) 0.289
Co-morbidities
 Charlson comorbidity index ≥1 151 (54.5) 117 (31.5) <0.001
 Diabetes mellitus 98 (35.4) 81 (21.8) <0.001
 Chronic renal disease 25 (9.0) 12 (3.2) 0.002
Clinical features
 Pitt score ≥1a 129 (46.6) 105 (28.3) <0.001
 Flank pain 69 (24.9) 97 (26.1) 0.721
 Symptom of lower urinary tract infection 164 (59.2) 249 (67.1) 0.038
 Costovertebral angle tenderness 164 (59.2) 242 (65.2) 0.117
Laboratory findings
 WBC≥20,000/mm3 36 (13) 24 (6.5) 0.005
 CRP≥20 mg/dL 100(36.1) 93 (25.1) 0.002
Clinical outcomes
 Discordant therapyb 22 (7.9) 20 (5.4) 0.192
 Duration of hospitalization (days, mean ± SD) 10.8 ± 7.2 8.1 ± 5.4 <0.001
 Defervescence time (days, mean ± SD) 3.2 ± 2.9 2.1 ± 2.5 0.014
 Hospital mortality 9/251 (3.6) 1/338 (0.3) 0.003
 Final clinical failure 20/251 (8.0) 9/338 (2.7) 0.003
a See method for calculation of Pitt scores.
bDiscordant therapy was defined as cases whose empirical antimicrobial therapy regimen was changed due to the drug resistance.
CA-APN, community-acquired acute pyelonephritis, WBC, white blood cell; CRP, C-reative protein; SD, standard deviation.
Table 4

Risk factors related to mortality in Community-acquired acute pyelonephritis

ic-49-22-i004
Characteristics Hospital mortality (n = 12) Final clinical failure (n = 38)
Univariate Multivariate Univariate Multivariate
N (%) OR (95% CI) P-value OR (95% CI) P-value N (%) OR (95% CI) P-value OR (95% CI) P-value
Age ≥70 years 8 (66.7) 5.038 (1.501-16.912) 0.007 17 (44.7) 2.062 (1.066-3.991) 0.029
Co-morbidities
 Charlson comorbidity index ≥1 9 (75.0) 4.521 (1.214-16.838) 0.018 3.964 (0.817-19.229) 0.087 26 (68.4) 3.396 (1.685-6.842) <0.001 3.909 (1.610-9.493) 0.003
 Diabetes mellitus 4 (33.3) 1.406 (0.419-4.723) 0.526 14 (36.8) 1.679 (0.851-3.316) 0.132
 Chronic renal disease 1 (8.3) 1.532 (0.193-12.157) 0.505 6 (15.8) 3.490 (1.371-8.882) 0.005
Laboratory findings
 WBC ≥20,000/mm3 5 (41.7) 6.863 (2.121-22.205) 0.004 11 (28.9) 4.158 (1.969-8.779) <0.001 3.472 (1.406-8.574) 0.007
 CRP ≥20 mg/dl 3 (25.0) 0.812 (0.218-3.029) 1.000 15 (39.5) 1.639 (0.839-3.204) 0.145
Positive blood culture 9/10 (90.0) 12.533 (1.577-99.578) 0.003 9.290 (1.145-75.392) 0.037 20/29 (69.0) 3.165 (1.416-7.076) 0.003
Discordant therapya 1 (8.3) 1.325 (0.167-10.483) 0.554 12 (31.6) 1.770 (0.872-3.593) 0.110 2.217 (1.001-4.912) 0.050
a Discordant therapy was defined as cases whose empirical antimicrobial therapy regimen was changed due to the drug resistance.
OR, odds ratio; CI, confidence interval; WBC, white blood cell; CRP, C-reactive protein.

3. Results of radiologic imaging studies

Of the 872 patients with CA-APN, 683 (78.3%) underwent abdominal CT (503, 57.7%), abdominal US (154, 17.7%) or both (24, 2.8%) within 7 days of admission. Abdominal CT was conducted in 527 patients at median 0 day (range, 0-7 days) after they visited the hospital because of: an uncertain diagnosis in 339 patients (64.3%), suspected structural abnormality in 86 (16.3%), persistent fever after 72 hours of antibiotic use in 20 (3.8%), male gender and adolescence in 32 and 4 (6.1%, 0.76%), respectively, severe sepsis in 19 (3.6%) and other reasons in 27 (5.1%). Abdominal US was conducted in 180 patients at median 1 day (range, 0-8 days) after hospital visit, due to diagnostic uncertainty in 74 patients (41.1%) and suspected structural abnormality in 30 patients (16.7%). Final radiologic findings were in Table 5. The APN detection rates were 84.4% (445/527) and 40% (72/180) by abdominal CT and abdominal US, respectively. As the final outcome of the radiologic imaging studies, 21 (4.0%) of the 527 patients undergoing abdominal CT and 5 of the 180 patients undergoing abdominal US (2.8%), respectively, underwent interventional procedures.
Table 5

Radiologic findings in abdominal computed tomography and abdominal ultrasonography

ic-49-22-i005
Radiologic finding Computed tomography Ultrasonography
Number % Number %
Number 29 3.98 66 36.67
APN 407 77.23 65 36.11
APN with urolithiasis 8 1.52 0 0.00
APN with hydronephrosis 6 1.14 3 1.67
APN with urolithiasis & hydronephrosis 1 0.19 0 0.00
Urolithasis 14 2.66 4 2.22
Hydronephrosis/hydroureter 16 3.04 6 3.33
Renal abscess 21 3.98 2 1.11
Perinephric abscess 1 0.19 1 0.56
APN with emphysematous cystitis 1 0.19 1 0.56
Medical renal disease/PKD 3 0.57 18 10.00
Others 20 3.80 14 7.78
Total 527 100 180 100
APN, acute pyelonephritis; PKD, polycystic kidney disease

4. Clinical characteristics of the CA-APN patients with structural abnormalities

In order to identify patients whose treatment might need to be modified by, for example, extending the treatment or carrying out interventional procedures, we compared the clinical characteristics of 81 patients with structural abnormalities, such as renal abscess, perinephric abscess, urolithiasis, hydronephorosis/hydroureter and emphysematous cystitis, with those of 602 patients without such lesions (Table 6). Patients with Pitt score ≥1, flank pain and azotemia were significantly more likely to have structural abnormalities that could potentially impact on treatment modalities. With regard to clinical outcomes in the 2 groups, defervescence time (3.5 vs. 2.5 days, P = 0.001) and duration of hospitalization (11.5 vs. 8.8 days, P <0.001) were significantly longer in the group with structural abnormalities, but there was no difference in final clinical failure or hospital mortality. For the evaluation of relationship between the early clinical failure and structural abnormalities, sub-group analysis was performed with 30 patients who underwent imaging studies for the reason of non-response of therapy after 72 hours. We divided into two groups depending on the structural abnormalities, and compared their clinical characteristics. However, there were no significant differences including final clinical failure and hospital mortality between two groups (data not shown).
Table 6

Clinical characteristics of the CA-APN patients with structural abnormalities

ic-49-22-i006
Clinical Characteristics With Structural abnormalities
N = 81
n (%)
Without Structural abnormalities
N = 602
n (%)
P-value
Age≥70 years 28 (34.6) 171 (28.4) 0.252
Underlying conditions
 Charlson co-morbidity index ≥1 33 (40.7) 248 (41.2) 0.938
 Diabetes mellitus 17 (21.0) 174 (28.9) 0.136
 Cerebrovascular disorder 10 (12.3) 54 (9.0) 0.328
 Congestive heart failure 2 (2.5) 36 (6.0) 0.299
 Dementia 6 (7.4) 18 (3.0) 0.054
 Chronic pulmonary disease 1 (1.2) 16 (2.7) 0.708
 Chronic liver disease 2 (2.5) 19 (3.2) 1.000
 Chronic bed ridden state 3 (3.7) 23 (3.8) 1.000
Past history
 History of urinary tract infection within 1 year 23/68 (33.8) 147/526 (27.9) 0.313
 History of admission within 1 year 24/73 (32.9) 131/548 (23.9) 0.096
 History antibiotics use within 1 year 24/59 (40.7) 163/494 (33.0) 0.238
Clinical findings
 Pitt score ≥1a 42 (51.9) 191 (31.7) <0.001
 Costovertebral angle tenderness 58 (71.6) 393 (65.3) 0.259
 Flank pain 33 (40.7) 179 (29.7) 0.044
 Lower urinary tract infection symptoms 49 (60.5) 389 (64.6) 0.468
Laboratory findings
 Hematuria (urine RBC > 5~9/HPF) 51 (63.0) 314 (52.2) 0.067
 Azotemiab 25 (30.9) 88 (14.6) <0.001
 WBC >20,000/mm3 11 (13.6) 61 (10.1) 0.343
 CRP >20 mg/dl 23 (28.4) 173 (28.7) 0.949
Clinical outcomes
 Duration of hospitalization (days, mean ± SD) 11.5 ± 6.7 8.8 ± 5.8 <0.001
 Defervescence time (days, mean ±SD) 3.5 ± 3.2 2.5 ± 2.3 0.001
 Hospital mortality 3 (4.2) 8 (1.4) 0.119
 Final clinical failure 6 (8.5) 25 (4.5) 0.150
aSee method for calculation of Pitt score
bAzotemia was defined as serum BUN ≥ 20 mg/dL and/or serum creatinine ≥ 2.0 mg/dL.
CA-APN, community-acquired acute pyelonephritis; RBC, red blood cell; HPF, high-power field; WBC, white blood cell; CRP, C-reactive protein; SD, standard deviation; BUN, blood urea nitrogen.

Discussion

APN is diagnosed by clinical signs and symptoms of upper urinary tract infection, and isolation of the pathogen from urine [4]. In clinical practice, blood cultures and radiologic imaging studies such as CT are commonly used [5613]. Although these tests have been performed on a substantial number of patients, there has been controversy as to their accuracy and usefulness. The purpose of this study was to evaluate the impact of blood cultures and radiologic tests on the management of CA-APN patients.
Retrospective studies have found that, generally, 70-90% of CA-APN patients undergo blood cultures [714]. Several reports have evaluated the usefulness of blood cultures in women with uncomplicated APN, and proposed that blood cultures do not provide additional useful information for clinical managements [2571415], as was also reported in the case of pregnant women with APN [16]. Even in complicated APN patients with structural or functional urinary tract abnormalities, blood cultures have limited value for treatment choices [6]. One report has shown that complicated CA-APN patients with bacteremia had more severe clinical manifestations with more severe sepsis or septic shock, resulting in longer defervescence and hospitalization times than those without bacteremia [17]. In the present study, different microorganisms were isolated from urine and blood cultures in 11 patients, and in 49 patients pathogens were isolated from blood only; therefore, blood cultures provided important information in 60 of the 645 patients (9.3%) in whom both urine and blood cultures were performed. Since quite a few patients coming to a tertiary hospital via a primary clinic have already been prescribed antibiotics, the 49 patients yielding only positive blood cultures could be explained by the fact that they had already taken sufficient antibiotic to sterilize their urine but not to their blood. Indeed, the positive rate of urine culture was lower (69.3%) in this report than in the aforementioned reports. Furthermore, CA-APN patients with positive blood culture were shown worse clinical outcomes and bacteremia was independent risk factor for hospital mortality in this study.
With regard to radiologic imaging studies for CA-APN, the American College of Radiology recommends waiting for 72 hours before carrying out any imaging [1819], and proposes CT as the imaging method of choice for diagnosing patients with atypical pyelonephritis [18]. Abdominal CT increases the sensitivity and specificity of diagnosis of APN, which enables confirmation of early lesions and is useful for locating the anatomical lesions in infected tissues and confirming abscesses and perirenal inflammation. Abdominal US has low sensitivity for detecting early APN but avoids radiation exposure, may be used in pregnant mothers and in children, and is useful for detecting renal parenchymal inflammation and confirming abscess formation [1120]. Generally, radiologic tests are performed in the following cases: 1) patients that are unresponsive in the first 72-hours of treatment, 2) intervention-requiring patients with structural and functional abnormalities of the urinary system, 3) high-risk patients with diabetes mellitus, old age, or taking immunosuppressants, and 4) cases requiring confirmation of bacterial infection infiltrating other organs [21]. However, intervention-requiring pyelonephritis patients could not be identified prior to imaging study. In a report that found very low rates of positive urine or blood cultures, CT and nuclear magnetic resonance were proposed as tools for diagnosis of APN, especially for detecting progression to abscess [13].
In this study, US and CT scans were carried out in more than 80% of CA-APN patients regardless of their responses to treatment, and mostly within 3 days. When we compared the demographic and clinical characteristics of the groups that did and did not undergo radiologic testing, we found no difference (data not shown), which suggests that clinicians did not follow any consistent principle in ordering radiologic tests. The rate of detection of infections in the kidney by US was very low, and CT missed over 10% of APN in this study, probably because most radiologic studies were performed early in the disease course. Nevertheless, radiologic imaging detected 81 patients (11.9%) with structural abnormalities which could potentially impact on clinical management, such as interventions and extension of treatment, among 683 patients with CA-APN. The prevalence of structural or functional abnormalities in CA-APN may vary according to the patient population, and the characteristics of the medical center or community; the 11.9% prevalence in this study was probably due to the fact that most of the enrolled patients were hospitalized and all but one of the institutions involved were university-affiliated tertiary hospitals. Nevertheless, we were able to identify clinical features that were more common in patients with structural abnormalities, namely Pitt score ≥1 and presence of flank pain or azotemia. Therefore, it might be helpful to use these abnormalities as indicators for deciding whether to carry out early radiologic studies in clinical practice.
The significance of this study is that it is a prospectively performed multi-center study of a large number of cases of CA-APN aiming to assess the impacts of blood cultures and radiologic imaging studies on therapeutic decision-making. Although it was principally an observational study without intervention, more than 80% of the patients underwent radiologic imaging studies. Because of this overuse of these tools, we were able to analyze the radiologic findings in a large number of CA-APN patients. However, this study also has a potential limitation in that most of the patients were hospitalized in a tertiary university hospital, and the patient population might have had on average a severe form of CA-APN. In addition, the impact of posivive blood culture tests on severe sepsis or septic shock was not assessed due to lack of collecting variables.
In conclusion, blood cultures performed early were clinically useful for diagnosing CA-APN, and bacteremia is predictive factor for hospital mortality. In terms of radiologic studies, more than 10% of the patients had structural abnormalities potentially influencing clinical management. Early radiologic imaging studies should be considered for CA-APN patients with Pitt score ≥1, or have flank pain or azotemia.

Acknowledgements

This work was supported by the research fund of Hanyang University (HY-2011).

Notes

Conflict of Interest No conflicts of interest

References

1. Czaja CA, Scholes D, Hooton TM, Stamm WE. Population-based epidemiologic analysis of acute pyelonephritis. Clin Infect Dis. 2007; 45:273–280.
crossref
2. Colgan R, Williams M, Johnson JR. Diagnosis and treatment of acute pyelonephritis in women. Am Fam Physician. 2011; 84:519–526.
3. Ki M, Park T, Choi B, Foxman B. The epidemiology of acute pyelonephritis in South Korea, 1997-1999. Am J Epidemiol. 2004; 160:985–993.
crossref
4. Sobel JD, Kaye D. Urinary tract infections. In : Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 8th ed. Philadephia: Elsevier;2015. p. 886–913.
5. Velasco M, Martínez JA, Moreno-Martínez A, Horcajada JP, Ruiz J, Barranco M, Almela M, Vila J, Mensa J. Blood cultures for women with uncomplicated acute pyelonephritis: are they necessary? Clin Infect Dis. 2003; 37:1127–1130.
crossref
6. Chen Y, Nitzan O, Saliba W, Chazan B, Colodner R, Raz R. Are blood cultures necessary in the management of women wih complicated pyelonephritis? J Infect. 2006; 53:235–240.
crossref
7. Thanassi M. Utility of urine and blood cultures in pyelonephritis. Acad Emerg Med. 1997; 4:797–800.
crossref
8. Calbo E, Romaní V, Xercavins M, Gómez L, Vidal CG, Quintana S, Vila J, Garau J. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum β-lactamases. J Antimicrob Chemother. 2006; 57:780–783.
crossref
9. Naber KG, Savov O, Salmen HC. Piperacillin 2g/tazobactam 0.5g is as effective as imipenem 0.5g/cilastatin 0.5g for the treatment of acute uncomplicated pyelonephritis and complicated urinary tract infections. Int J Antimicrob Agents. 2002; 19:95–103.
crossref
10. Talan DA, Stamm WE, Hooton TM, Moran GJ, Burke T, Iravani A, Reuning-Scherer J, Church DA. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial. JAMA. 2000; 283:1583–1590.
crossref
11. Stunell H, Buckley O, Feeney J, Geoghegan T, Browne RF, Torreggiani WC. Imaging of acute pyelonephritis in the adult. Eur Radiol. 2007; 17:1820–1828.
crossref
12. Rhee JY, Kwon KT, Ki HK, Shin SY, Jung DS, Chung DR, Ha BC, Peck KR, Song JH. Scoring systems for prediction of mortality in patients with intensive care unit-acquired sepsis: a comparison of the Pitt bacteremia score and the Acute Physiology and Chronic Health Evaluation II scoring systems. Shock. 2009; 31:146–150.
crossref
13. Rollino C, Beltrame G, Ferro M, Quattrocchio G, Sandrone M, Quarello F. Acute pyelonephritis in adults: a case series of 223 patients. Nephrol Dial Transplant. 2012; 27:3488–3493.
crossref
14. McMurray BR, Wrenn KD, Wright SW. Usefulness of blood cultures in pyelonephritis. Am J Emerg Med. 1997; 15:137–140.
crossref
15. Mills AM, Barros S. Are blood cultures necessary in adults with pyelonephritis? Ann Emerg Med. 2005; 46:285–287.
crossref
16. Wing DA, Park AS, Debuque L, Millar LK. Limited clinical utility of blood and urine cultures in the treatment of acute pyelonephritis during pregnancy. Am J Obstet Gynecol. 2000; 182:1437–1440.
crossref
17. Hsu CY, Fang HC, Chou KJ, Chen CL, Lee PT, Chung HM. The clinical impact of bacteremia in complicated acute pyelonephritis. Am J Med Sci. 2006; 332:175–180.
crossref
18. Agency for Healthcare Research and Quality (AHRQ). American College of Radiology appropriateness criteria® acute pyelonephritis. Accessed 11 August 2016. Available at: http://www.guideline.gov/content.aspx?id=37923.
19. Soulen MC, Fishman EK, Goldman SM, Gatewood OM. Bacterial renal infection: role of CT. Radiology. 1989; 171:703–707.
crossref
20. Mitterberger M, Pinggera GM, Colleselli D, Bartsch G, Strasser H, Steppan I, Pallwein L, Friedrich A, Gradl J, Frauscher F. Acute pyelonephritis: comparison of diagnosis with computed tomography and contrast-enhanced ultrasonography. BJU Int. 2008; 101:341–344.
crossref
21. Abraham G, Reddy YN, George G. Diagnosis of acute pyelonephritis with recent trends in management. Nephrol Dial Transplant. 2012; 27:3391–3394.
crossref
TOOLS
ORCID iDs

Yeonjae Kim
https://orcid.org/http://orcid.org/0000-0003-4144-9077

Hyunjoo Pai
https://orcid.org/http://orcid.org/0000-0003-4143-035X

Similar articles